Chemotherapeutic agent cisplatin monitoring in biological fluids by means of inductively-coupled plasma emission spectrometry (ICP-AES)

Clinica Chimica Acta; International Journal of Clinical Chemistry
C DominiciM A Castello

Abstract

The antitumoral agent cis-diamminedichloroplatinum (II) was administered at doses of 40 mg m-2 body surface area daily for 5 days via continuous i.v. infusion in association with etoposide (VP-16-213). The Pt concentration in serum up to 30 days from the beginning of the therapy was monitored by inductively-coupled plasma emission spectrometry. Results lead to two main conclusions: the analytical technique employed is suitable for measurements of Pt in biological fluids with the necessary precision (0.95-2.5%), accuracy (recovery 98.5-101.7%) and detection power (0.002-0.004 mg/l); there were effective Pt plasma concentrations for a greater length of time (with peak value 2.0 mg/l towards the end of treatment) than those achieved by other therapies so far adopted. On the other hand, toxic side effects, in particular gastrointestinal toxicity, myelosuppression and nephrotoxicity, were found to be not worse than those generally caused by the administration of the chemotherapeutic compound at lower doses. Both aspects were deeded to be essential prerequisites for better exploiting the drug's effectiveness.

References

Aug 1, 1978·The American Journal of Medicine·N E Madias, J T Harrington
Jan 1, 1985·Cancer Chemotherapy and Pharmacology·B J CordenJ M Collins
Apr 26, 1969·Nature·B RosenbergV H Mansour
Jan 1, 1984·Annals of Internal Medicine·R F OzolsR C Young
Jul 1, 1981·Clinica Chimica Acta; International Journal of Clinical Chemistry·J Smeyers-VerbekeD L Massart
Nov 1, 1981·Annals of Internal Medicine·J D Blachley, J B Hill

❮ Previous
Next ❯

Citations

Jun 19, 1992·Pharmaceutisch Weekblad. Scientific Edition·T J HodesJ H Beijnen
Feb 15, 1989·Clinica Chimica Acta; International Journal of Clinical Chemistry·R A NewmanZ H Siddik
Jul 9, 2013·Journal of Pharmaceutical and Biomedical Analysis·F P VieiraJ N Silveira
Nov 1, 1991·Biological Mass Spectrometry·G K PoonS Lewis
Jan 1, 1990·Journal of Pharmaceutical and Biomedical Analysis·W A De WaalJ C Kraak
Jan 1, 1988·Journal of Pharmaceutical and Biomedical Analysis·C M Riley
Nov 1, 1995·Journal of Pharmaceutical and Biomedical Analysis·G K PoonC F Barnard
Dec 31, 1997·Journal of Pharmaceutical and Biomedical Analysis·R MilacicG Sersa
Oct 3, 1999·Annals of Clinical Biochemistry·J D HoldingP M Stell
Jul 1, 1993·Journal of the American Society for Mass Spectrometry·G K PoonP Mistry

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.